All Work

Chris Lange

How Analysts Rate Fitbit After Earnings

While Fitbit had outstanding earnings for the quarter, the stock was absolutely devastated by the guidance for the first quarter.

Chris Lange · 11 years ago

Syndax Updates IPO FIling

Syndax Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange · 11 years ago

Why Peregrine Absolutely Tanked

Peregine Pharmaceuticals has announced that it is discontinuing its Phase 3 Sunrise trial of bavituximab in patients with previously treated locally advanced or metastatic non-squamous non-small cell lung cancer.

Chris Lange · 11 years ago

Wingstop Sets Up for Secondary Offering

Wingstop plans to offer 5 million shares in a secondary offering valued up to more than $132 million, at the most recent closing price.

Chris Lange · 11 years ago

Gap Guidance Falls Short of Investor Expectations

The Gap, Inc. (NYSE: GPS) reported its fiscal fourth-quarter financial results after the markets closed on Thursday. The company had $0.57 in earnings per share (EPS) on $4.39 billion in revenue versus Thomson Reuters…

Chris Lange · 11 years ago

Is 45% Revenue Growth Guidance Enough for Palo Alto?

Palo Alto Networks, Inc. (NYSE: PANW) released its fiscal second-quarter financial results prematurely before the markets closed on Thursday.  Its shares initially popped higher on the news, but shares were halted after the news.…

Chris Lange · 11 years ago

Cybersecurity Short Interest Gains Momentum

The February 12 short interest data have been compared with the previous figures, and short interest for the selected cybersecurity stocks increased.

Chris Lange · 11 years ago